Wednesday - February 4, 2026
FDA Issues Warning Letter to Kirkman
February 04, 2026
WASHINGTON, Feb. 4 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to HTO Nevada Inc. dba Kirkman from the Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Eric Jon Gripentrog, Chief Executive Officer, HTO Nevada, Inc. dba Kirkman, 6400 Rosewood Street, Lake Oswego, OR 97035-5392, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States
. . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products